← Back to Search

Cancer Screening Test

Treatment for Colorectal Cancer (NICE Trial)

N/A
Waitlist Available
Research Sponsored by Venn Biosciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days from baseline
Awards & highlights

Summary

The NICE study is a prospective, multi-site study to train and validate a blood-based, glycoproteomic test for the early detection of advanced adenoma and colorectal cancer by collecting blood samples and associated relevant clinical information from average-risk participants who undergo routine screening colonoscopy as well as participants undergoing colonoscopy for surveillance or diagnostic indications

Eligible Conditions
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity of the InterVenn test
Specificity of the InterVenn test

Find a Location

Who is running the clinical trial?

Venn Biosciences CorporationLead Sponsor
2 Previous Clinical Trials
1,025 Total Patients Enrolled
Daniel Hommes, MDStudy DirectorInterVenn Biosciences
2 Previous Clinical Trials
1,200 Total Patients Enrolled
~901 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top